0.025485 0.000000 0.000000 0.000000 0.025485 0.000000 0.000000 0.000000 0.008006 0.00000 0.00000 0.00000 Brzozowski, A.M. Jiracek, J. Zakova, L. Antolikova, E. Watson, C.J. Turkenburg, J.P. Dodson, G.G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 16 90.00 90.00 90.00 39.239 39.239 124.908 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C4 H9 N O2 103.120 n N-methyl-L-alanine L-peptide linking Na 1 22.990 SODIUM ION non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking N 1 N N N 2 S C N 3 N C N 4 N O N 5 N C N 6 N O N 7 N H N 8 N H N 9 N H N 10 N H N 11 N H N 12 N H N 13 N H N 14 N N N 15 S C N 16 N C N 17 N O N 18 N C N 19 N C N 20 N C N 21 N N N 22 N C N 23 N N N 24 N N N 25 N O N 26 N H N 27 N H N 28 N H N 29 N H N 30 N H N 31 N H N 32 N H N 33 N H N 34 N H N 35 N H N 36 N H N 37 N H N 38 N H N 39 N H N 40 N H N 41 N N N 42 S C N 43 N C N 44 N O N 45 N C N 46 N C N 47 N O N 48 N N N 49 N O N 50 N H N 51 N H N 52 N H N 53 N H N 54 N H N 55 N H N 56 N H N 57 N H N 58 N N N 59 R C N 60 N C N 61 N O N 62 N C N 63 N S N 64 N O N 65 N H N 66 N H N 67 N H N 68 N H N 69 N H N 70 N H N 71 N H N 72 N N N 73 S C N 74 N C N 75 N O N 76 N C N 77 N C N 78 N C N 79 N O N 80 N N N 81 N O N 82 N H N 83 N H N 84 N H N 85 N H N 86 N H N 87 N H N 88 N H N 89 N H N 90 N H N 91 N H N 92 N N N 93 S C N 94 N C N 95 N O N 96 N C N 97 N C N 98 N C N 99 N O N 100 N O N 101 N O N 102 N H N 103 N H N 104 N H N 105 N H N 106 N H N 107 N H N 108 N H N 109 N H N 110 N H N 111 N N N 112 N C N 113 N C N 114 N O N 115 N O N 116 N H N 117 N H N 118 N H N 119 N H N 120 N H N 121 N N N 122 S C N 123 N C N 124 N O N 125 N C Y 126 N C Y 127 N N Y 128 N C Y 129 N C Y 130 N N N 131 N O N 132 N H N 133 N H N 134 N H N 135 N H N 136 N H N 137 N H N 138 N H N 139 N H N 140 N H N 141 N H N 142 N O N 143 N H N 144 N H N 145 N N N 146 S C N 147 N C N 148 N O N 149 S C N 150 N C N 151 N C N 152 N C N 153 N O N 154 N H N 155 N H N 156 N H N 157 N H N 158 N H N 159 N H N 160 N H N 161 N H N 162 N H N 163 N H N 164 N H N 165 N H N 166 N H N 167 N N N 168 S C N 169 N C N 170 N O N 171 N C N 172 N C N 173 N C N 174 N C N 175 N O N 176 N H N 177 N H N 178 N H N 179 N H N 180 N H N 181 N H N 182 N H N 183 N H N 184 N H N 185 N H N 186 N H N 187 N H N 188 N H N 189 N N N 190 S C N 191 N C N 192 N O N 193 N C N 194 N C N 195 N C N 196 N C N 197 N N N 198 N O N 199 N H N 200 N H N 201 N H N 202 N H N 203 N H N 204 N H N 205 N H N 206 N H N 207 N H N 208 N H N 209 N H N 210 N H N 211 N H N 212 N H N 213 N H N 214 N N N 215 N C N 216 S C N 217 N C N 218 N C N 219 N O N 220 N O N 221 N H N 222 N H N 223 N H N 224 N H N 225 N H N 226 N H N 227 N H N 228 N H N 229 N H N 230 N NA N 231 N N N 232 S C N 233 N C N 234 N O N 235 N C Y 236 N C Y 237 N C Y 238 N C Y 239 N C Y 240 N C Y 241 N C N 242 N O N 243 N H N 244 N H N 245 N H N 246 N H N 247 N H N 248 N H N 249 N H N 250 N H N 251 N H N 252 N H N 253 N H N 254 N N N 255 S C N 256 N C N 257 N O N 258 N C N 259 N C N 260 N C N 261 N O N 262 N H N 263 N H N 264 N H N 265 N H N 266 N H N 267 N H N 268 N H N 269 N H N 270 N H N 271 N N N 272 S C N 273 N C N 274 N O N 275 N C N 276 N O N 277 N O N 278 N H N 279 N H N 280 N H N 281 N H N 282 N H N 283 N H N 284 N H N 285 N N N 286 S C N 287 N C N 288 N O N 289 R C N 290 N O N 291 N C N 292 N O N 293 N H N 294 N H N 295 N H N 296 N H N 297 N H N 298 N H N 299 N H N 300 N H N 301 N H N 302 N N N 303 S C N 304 N C N 305 N O N 306 N C Y 307 N C Y 308 N C Y 309 N C Y 310 N C Y 311 N C Y 312 N C N 313 N O N 314 N O N 315 N H N 316 N H N 317 N H N 318 N H N 319 N H N 320 N H N 321 N H N 322 N H N 323 N H N 324 N H N 325 N H N 326 N N N 327 S C N 328 N C N 329 N O N 330 N C N 331 N C N 332 N C N 333 N O N 334 N H N 335 N H N 336 N H N 337 N H N 338 N H N 339 N H N 340 N H N 341 N H N 342 N H N 343 N H N 344 N H N 1 N sing N 2 N sing N 3 N sing N 4 N sing N 5 N sing N 6 N sing N 7 N doub N 8 N sing N 9 N sing N 10 N sing N 11 N sing N 12 N sing N 13 N sing N 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N doub N 20 N sing N 21 N sing N 22 N sing N 23 N sing N 24 N sing N 25 N sing N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N doub N 34 N sing N 35 N sing N 36 N sing N 37 N sing N 38 N sing N 39 N sing N 40 N sing N 41 N sing N 42 N sing N 43 N sing N 44 N sing N 45 N doub N 46 N sing N 47 N sing N 48 N sing N 49 N sing N 50 N doub N 51 N sing N 52 N sing N 53 N sing N 54 N sing N 55 N sing N 56 N sing N 57 N sing N 58 N sing N 59 N sing N 60 N sing N 61 N doub N 62 N sing N 63 N sing N 64 N sing N 65 N sing N 66 N sing N 67 N sing N 68 N sing N 69 N sing N 70 N sing N 71 N sing N 72 N sing N 73 N sing N 74 N doub N 75 N sing N 76 N sing N 77 N sing N 78 N sing N 79 N sing N 80 N sing N 81 N sing N 82 N doub N 83 N sing N 84 N sing N 85 N sing N 86 N sing N 87 N sing N 88 N sing N 89 N sing N 90 N sing N 91 N sing N 92 N sing N 93 N doub N 94 N sing N 95 N sing N 96 N sing N 97 N sing N 98 N sing N 99 N sing N 100 N sing N 101 N doub N 102 N sing N 103 N sing N 104 N sing N 105 N sing N 106 N sing N 107 N sing N 108 N sing N 109 N sing N 110 N sing N 111 N doub N 112 N sing N 113 N sing N 114 N sing N 115 N sing N 116 N sing N 117 N sing N 118 N sing N 119 N sing N 120 N doub N 121 N sing N 122 N sing N 123 N sing N 124 N sing Y 125 N sing Y 126 N doub Y 127 N doub N 128 N sing Y 129 N sing N 130 N sing Y 131 N sing N 132 N sing N 133 N sing N 134 N sing N 135 N sing N 136 N sing N 137 N sing N 138 N sing N 139 N sing N 140 N sing N 141 N sing N 142 N sing N 143 N doub N 144 N sing N 145 N sing N 146 N sing N 147 N sing N 148 N sing N 149 N sing N 150 N sing N 151 N sing N 152 N sing N 153 N sing N 154 N sing N 155 N sing N 156 N sing N 157 N sing N 158 N sing N 159 N sing N 160 N sing N 161 N sing N 162 N sing N 163 N sing N 164 N doub N 165 N sing N 166 N sing N 167 N sing N 168 N sing N 169 N sing N 170 N sing N 171 N sing N 172 N sing N 173 N sing N 174 N sing N 175 N sing N 176 N sing N 177 N sing N 178 N sing N 179 N sing N 180 N sing N 181 N sing N 182 N sing N 183 N sing N 184 N sing N 185 N doub N 186 N sing N 187 N sing N 188 N sing N 189 N sing N 190 N sing N 191 N sing N 192 N sing N 193 N sing N 194 N sing N 195 N sing N 196 N sing N 197 N sing N 198 N sing N 199 N sing N 200 N sing N 201 N sing N 202 N sing N 203 N sing N 204 N sing N 205 N sing N 206 N sing N 207 N sing N 208 N sing N 209 N sing N 210 N sing N 211 N sing N 212 N sing N 213 N sing N 214 N sing N 215 N doub N 216 N sing N 217 N sing N 218 N sing N 219 N sing N 220 N sing N 221 N sing N 222 N sing N 223 N sing N 224 N doub N 225 N sing N 226 N sing N 227 N sing N 228 N sing Y 229 N doub Y 230 N sing Y 231 N sing N 232 N sing Y 233 N doub N 234 N sing Y 235 N doub N 236 N sing Y 237 N sing N 238 N sing N 239 N sing N 240 N sing N 241 N sing N 242 N sing N 243 N sing N 244 N sing N 245 N sing N 246 N sing N 247 N doub N 248 N sing N 249 N sing N 250 N sing N 251 N sing N 252 N sing N 253 N sing N 254 N sing N 255 N sing N 256 N sing N 257 N sing N 258 N sing N 259 N sing N 260 N sing N 261 N sing N 262 N sing N 263 N sing N 264 N doub N 265 N sing N 266 N sing N 267 N sing N 268 N sing N 269 N sing N 270 N sing N 271 N sing N 272 N sing N 273 N sing N 274 N sing N 275 N sing N 276 N sing N 277 N doub N 278 N sing N 279 N sing N 280 N sing N 281 N sing N 282 N sing N 283 N sing N 284 N sing N 285 N sing N 286 N sing N 287 N sing N 288 N sing N 289 N sing N 290 N sing N 291 N sing N 292 N sing N 293 N doub N 294 N sing N 295 N sing N 296 N sing N 297 N sing Y 298 N doub Y 299 N sing Y 300 N sing N 301 N sing Y 302 N doub N 303 N sing Y 304 N doub N 305 N sing Y 306 N sing N 307 N sing N 308 N sing N 309 N sing N 310 N sing N 311 N sing N 312 N sing N 313 N sing N 314 N sing N 315 N sing N 316 N sing N 317 N doub N 318 N sing N 319 N sing N 320 N sing N 321 N sing N 322 N sing N 323 N sing N 324 N sing N 325 N sing N 326 N sing N 327 N sing N 328 N sing US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 107 1966 10.1073/PNAS.0911785107 20133841 Implications for the Active Form of Human Insulin Based on the Structural Convergence of Highly Active Hormone Analogues. 2010 10.2210/pdb2wrx/pdb pdb_00002wrx ARG B 22 C-ALPHA IS PLANAR 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 CCD 2008-01-30 ADSC CCD SINGLE WAVELENGTH M x-ray 1 1.07230 1.0 ID14-1 ESRF 1.07230 SYNCHROTRON ESRF BEAMLINE ID14-1 2383.698 INSULIN A CHAIN 2 syn polymer METHYLATION OF B26 AND D26 PEPTIDE NITROGEN ATOM IN B AND D CHAIN OF HUMAN INSULIN 3355.884 INSULIN B CHAIN YES 2 syn polymer 22.990 SODIUM ION 1 syn non-polymer 18.015 water 101 nat water no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A,C polypeptide(L) no yes FVNQHLCGSHLVEALYLVCGERGFF(MAA)TPKT FVNQHLCGSHLVEALYLVCGERGFFATPKT B,D polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 2.4 48 NONE 3.0 0.18 M LI2SO4, 0.1M NA ACETATE PH 3.0 chem_comp_atom chem_comp_bond database_2 pdbx_database_status pdbx_initial_refinement_model pdbx_struct_conn_angle struct_conn struct_site repository Initial release Advisory Atomic model Database references Derived calculations Non-polymer description Other Version format compliance Data collection Database references Derived calculations Other Refinement description 1 0 2010-02-09 1 1 2012-04-04 1 2 2023-12-20 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_sf _pdbx_struct_conn_angle.ptnr1_auth_asym_id _pdbx_struct_conn_angle.ptnr1_auth_seq_id _pdbx_struct_conn_angle.ptnr1_label_asym_id _pdbx_struct_conn_angle.ptnr3_auth_asym_id _pdbx_struct_conn_angle.ptnr3_auth_seq_id _pdbx_struct_conn_angle.ptnr3_label_asym_id _pdbx_struct_conn_angle.value _struct_conn.pdbx_dist_value _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr2_auth_asym_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_asym_id _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES) NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10- ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE) INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12- ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES STRUCTURE OF INSULIN CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN T6 HUMAN INSULIN AT 1.0 A RESOLUTION CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS. FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE) INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2) NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12- ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)]; FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES DEHYDRATED T6 HUMAN INSULIN AT 295 K INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION. R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28) ->THR] INSULIN MUTANT (PT INSULIN) NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL DEHYDRATED T6 HUMAN INSULIN AT 100 K HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS- B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10- ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10- ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D; CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC- FREE, 10 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS- B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A- CHAINVARIANT INSULIN WAKAYAMA R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K INSULIN, MONOCLINIC CRYSTAL FORM STRUCTURE OF INSULIN INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES) HUMAN INSULIN MUTANT SERB9GLU R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT. INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES) LYS(B28)PRO(B29)-HUMAN INSULIN AN ACTIVE MINI-PROINSULIN, M2PI NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12- THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3- GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN MONOMER FORM SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER FORM SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D- PROB26-DTI-NH2 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26-DTI-NH2 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26-DTI-NH2 PDBE Y PDBE 2009-09-02 REL REL NA SODIUM ION HOH water 9606 HUMAN HOMO SAPIENS sample 9606 HUMAN HOMO SAPIENS sample ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO MAA ENGINEERED RESIDUE IN CHAIN D, TYR 50 TO MAA SODIUM (NA): SODIUM CATION 26 TYR MUTATED TO ALA AND N ATOM OF B26 PEPTIDE IS METHYLATED 26 TYR MUTATED TO ALA AND N ATOM OF D26 PEPTIDE IS METHYLATED 1MSO PDB ENTRY 1MSO PDB experimental model NA 2000 3 NA NA 2000 A HOH 2001 4 HOH HOH 2001 A HOH 2002 4 HOH HOH 2002 A HOH 2003 4 HOH HOH 2003 A HOH 2004 4 HOH HOH 2004 A HOH 2005 4 HOH HOH 2005 A HOH 2006 4 HOH HOH 2006 A HOH 2007 4 HOH HOH 2007 A HOH 2008 4 HOH HOH 2008 A HOH 2009 4 HOH HOH 2009 A HOH 2010 4 HOH HOH 2010 A HOH 2011 4 HOH HOH 2011 A HOH 2012 4 HOH HOH 2012 A HOH 2013 4 HOH HOH 2013 A HOH 2014 4 HOH HOH 2014 A HOH 2015 4 HOH HOH 2015 A HOH 2016 4 HOH HOH 2016 A HOH 2017 4 HOH HOH 2017 A HOH 2018 4 HOH HOH 2018 A HOH 2019 4 HOH HOH 2019 A HOH 2020 4 HOH HOH 2020 A HOH 2021 4 HOH HOH 2021 A HOH 2022 4 HOH HOH 2022 A HOH 2023 4 HOH HOH 2023 A HOH 2024 4 HOH HOH 2024 A HOH 2025 4 HOH HOH 2025 A HOH 2001 4 HOH HOH 2001 B HOH 2002 4 HOH HOH 2002 B HOH 2003 4 HOH HOH 2003 B HOH 2004 4 HOH HOH 2004 B HOH 2005 4 HOH HOH 2005 B HOH 2006 4 HOH HOH 2006 B HOH 2007 4 HOH HOH 2007 B HOH 2008 4 HOH HOH 2008 B HOH 2009 4 HOH HOH 2009 B HOH 2010 4 HOH HOH 2010 B HOH 2011 4 HOH HOH 2011 B HOH 2012 4 HOH HOH 2012 B HOH 2013 4 HOH HOH 2013 B HOH 2014 4 HOH HOH 2014 B HOH 2015 4 HOH HOH 2015 B HOH 2016 4 HOH HOH 2016 B HOH 2017 4 HOH HOH 2017 B HOH 2018 4 HOH HOH 2018 B HOH 2019 4 HOH HOH 2019 B HOH 2020 4 HOH HOH 2020 B HOH 2021 4 HOH HOH 2021 B HOH 2022 4 HOH HOH 2022 B HOH 2001 4 HOH HOH 2001 C HOH 2002 4 HOH HOH 2002 C HOH 2003 4 HOH HOH 2003 C HOH 2004 4 HOH HOH 2004 C HOH 2005 4 HOH HOH 2005 C HOH 2006 4 HOH HOH 2006 C HOH 2007 4 HOH HOH 2007 C HOH 2008 4 HOH HOH 2008 C HOH 2009 4 HOH HOH 2009 C HOH 2010 4 HOH HOH 2010 C HOH 2011 4 HOH HOH 2011 C HOH 2012 4 HOH HOH 2012 C HOH 2013 4 HOH HOH 2013 C HOH 2014 4 HOH HOH 2014 C HOH 2015 4 HOH HOH 2015 C HOH 2016 4 HOH HOH 2016 C HOH 2017 4 HOH HOH 2017 C HOH 2018 4 HOH HOH 2018 C HOH 2019 4 HOH HOH 2019 C HOH 2020 4 HOH HOH 2020 C HOH 2021 4 HOH HOH 2021 C HOH 2022 4 HOH HOH 2022 C HOH 2023 4 HOH HOH 2023 C HOH 2024 4 HOH HOH 2024 C HOH 2001 4 HOH HOH 2001 D HOH 2002 4 HOH HOH 2002 D HOH 2003 4 HOH HOH 2003 D HOH 2004 4 HOH HOH 2004 D HOH 2005 4 HOH HOH 2005 D HOH 2006 4 HOH HOH 2006 D HOH 2007 4 HOH HOH 2007 D HOH 2008 4 HOH HOH 2008 D HOH 2009 4 HOH HOH 2009 D HOH 2010 4 HOH HOH 2010 D HOH 2011 4 HOH HOH 2011 D HOH 2012 4 HOH HOH 2012 D HOH 2013 4 HOH HOH 2013 D HOH 2014 4 HOH HOH 2014 D HOH 2015 4 HOH HOH 2015 D HOH 2016 4 HOH HOH 2016 D HOH 2017 4 HOH HOH 2017 D HOH 2018 4 HOH HOH 2018 D HOH 2019 4 HOH HOH 2019 D HOH 2020 4 HOH HOH 2020 D HOH 2021 4 HOH HOH 2021 D HOH 2022 4 HOH HOH 2022 D HOH 2023 4 HOH HOH 2023 D HOH 2024 4 HOH HOH 2024 D HOH 2025 4 HOH HOH 2025 D HOH 2026 4 HOH HOH 2026 D HOH 2027 4 HOH HOH 2027 D HOH 2028 4 HOH HOH 2028 D HOH 2029 4 HOH HOH 2029 D HOH 2030 4 HOH HOH 2030 D GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A n 1 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B MAA 26 n 26 MAA 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B n 29 29 B n 30 30 B GLY 1 n 1 GLY 1 C ILE 2 n 2 ILE 2 C VAL 3 n 3 VAL 3 C GLU 4 n 4 GLU 4 C GLN 5 n 5 GLN 5 C CYS 6 n 6 CYS 6 C CYS 7 n 7 CYS 7 C THR 8 n 8 THR 8 C SER 9 n 9 SER 9 C ILE 10 n 10 ILE 10 C CYS 11 n 11 CYS 11 C SER 12 n 12 SER 12 C LEU 13 n 13 LEU 13 C TYR 14 n 14 TYR 14 C GLN 15 n 15 GLN 15 C LEU 16 n 16 LEU 16 C GLU 17 n 17 GLU 17 C ASN 18 n 18 ASN 18 C TYR 19 n 19 TYR 19 C CYS 20 n 20 CYS 20 C ASN 21 n 21 ASN 21 C n 1 1 D VAL 2 n 2 VAL 2 D ASN 3 n 3 ASN 3 D GLN 4 n 4 GLN 4 D HIS 5 n 5 HIS 5 D LEU 6 n 6 LEU 6 D CYS 7 n 7 CYS 7 D GLY 8 n 8 GLY 8 D SER 9 n 9 SER 9 D HIS 10 n 10 HIS 10 D LEU 11 n 11 LEU 11 D VAL 12 n 12 VAL 12 D GLU 13 n 13 GLU 13 D ALA 14 n 14 ALA 14 D LEU 15 n 15 LEU 15 D TYR 16 n 16 TYR 16 D LEU 17 n 17 LEU 17 D VAL 18 n 18 VAL 18 D CYS 19 n 19 CYS 19 D GLY 20 n 20 GLY 20 D GLU 21 n 21 GLU 21 D ARG 22 n 22 ARG 22 D GLY 23 n 23 GLY 23 D PHE 24 n 24 PHE 24 D PHE 25 n 25 PHE 25 D MAA 26 n 26 MAA 26 D THR 27 n 27 THR 27 D PRO 28 n 28 PRO 28 D n 29 29 D n 30 30 D 0.8900 -1.0387 0.3188 5.8128 -1.4872 3.1336 -0.2104 -0.0773 0.0381 0.2535 0.3001 0.1191 -0.0732 -0.3912 -0.0897 0.0671 0.0413 -0.0136 0.0871 -0.0040 0.0272 refined 2.9776 17.9637 24.4580 X-RAY DIFFRACTION 1.6061 -0.0111 0.1928 3.2814 -2.2017 5.0776 -0.0731 -0.1265 0.0015 -0.2569 0.1590 0.1646 0.3006 -0.5990 -0.0859 0.0922 -0.0700 -0.0022 0.1154 -0.0083 0.0272 refined 1.9202 19.7296 8.1554 X-RAY DIFFRACTION A 1 A 21 X-RAY DIFFRACTION 1 B 2 B 29 X-RAY DIFFRACTION 1 C 1 C 21 X-RAY DIFFRACTION 2 D 2 D 28 X-RAY DIFFRACTION 2 author_and_software_defined_assembly PISA 4 tetrameric 3490 -46.3 6120 A HOH 2001 F O HOH 1_555 A NA 2000 E NA NA 1_555 B HOH 2019 G O HOH 1_555 138.8 A HOH 2001 F O HOH 1_555 A NA 2000 E NA NA 1_555 D HOH 2026 I O HOH 1_555 77.0 B HOH 2019 G O HOH 1_555 A NA 2000 E NA NA 1_555 D HOH 2026 I O HOH 1_555 117.5 B MAA 26 N-METHYL-L-ALANINE B MAA 26 ALA D MAA 26 N-METHYL-L-ALANINE D MAA 26 ALA 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 B CG GLU 21 B CG GLU 21 0 Y 1 B CD GLU 21 B CD GLU 21 0 Y 1 B OE1 GLU 21 B OE1 GLU 21 0 Y 1 B OE2 GLU 21 B OE2 GLU 21 0 Y 1 B CB ARG 22 B CB ARG 22 0 Y 1 B CG ARG 22 B CG ARG 22 0 Y 1 B CD ARG 22 B CD ARG 22 0 Y 1 B NE ARG 22 B NE ARG 22 0 Y 1 B CZ ARG 22 B CZ ARG 22 0 Y 1 B NH1 ARG 22 B NH1 ARG 22 0 Y 1 B NH2 ARG 22 B NH2 ARG 22 0 Y 1 D CG GLU 21 D CG GLU 21 0 Y 1 D CD GLU 21 D CD GLU 21 0 Y 1 D OE1 GLU 21 D OE1 GLU 21 0 Y 1 D OE2 GLU 21 D OE2 GLU 21 0 Y 1 B PHE 1 B PHE 1 1 Y 1 B LYS 29 B LYS 29 1 Y 1 B THR 30 B THR 30 1 Y 1 D PHE 1 D PHE 1 1 Y 1 D LYS 29 D LYS 29 1 Y 1 D THR 30 D THR 30 1 Y 1 B CA ARG 22 PLANAR 1 B B GLU ARG 21 22 73.93 1 17.30 2.70 111.00 128.30 B B B N CA C GLU GLU GLU 21 21 21 N 1 32.07 2.00 110.40 142.47 B B B CB CA C ARG ARG ARG 22 22 22 N 1 17.70 2.20 113.40 131.10 B B B CA CB CG ARG ARG ARG 22 22 22 N 1 B B CA CB ARG ARG 22 22 -0.440 0.022 1.535 1.095 N 1 D D CB CG GLU GLU 13 13 0.115 0.019 1.517 1.632 N 1 D D CB CG GLU GLU 21 21 -0.183 0.019 1.517 1.334 N 1 A C O O HOH HOH 2019 2005 0.00 1_555 5_555 1 A C OE1 OE2 GLU GLU 4 4 1.72 1_555 5_555 1 B ARG 22 68.41 -110.83 1 B MAA 26 -117.21 53.30 1 C CYS 7 -96.14 -61.00 17.567 0.78 0.00 0.00 0.78 0.00 -1.55 0.966 0.948 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES RESIDUAL ONLY. B1 PHE IS NOT MODELLED. B29 LYS AND B30 THR ARE NOT MODELLED. B21 GLU SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. B22 ARG SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. D1 PHE IS NOT MODELLED. D29 LYS AND D30 THR ARE NOT MODELLED. D21 GLU SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. D22 ARG SIDE CHAIN IS MOBILE AND ITS OCCUPANCY IS SET TO ZERO. 0.25053 0.18019 0.18343 1.50 37.42 787 14801 5.0 94.63 4.273 0.069 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.096 0.093 0.80 0.80 1.20 PDB ENTRY 1MSO MAXIMUM LIKELIHOOD MASK 1.50 37.42 101 844 1 0 742 0.023 0.022 767 1.980 1.954 1051 9.222 5.000 100 32.862 25.294 34 11.362 15.000 114 21.593 15.000 1 0.146 0.200 122 0.010 0.020 581 1.980 1.500 485 2.826 2.000 777 3.877 3.000 282 5.540 4.500 270 2.291 3.000 767 8.454 3.000 102 5.535 3.000 745 0.312 0.283 1.539 33 649 20 57.70 20.2 1.50 30.00 2WRX 17552 0.0 0.06 1 9.20 13.4 94.6 0.47 1.50 1.55 5.50 1 1.5 60.5 refinement REFMAC 5.5.0082 data reduction DENZO data scaling SCALEPACK phasing MOLREP Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0 1 N N 2 N N 1 N N 2 N N 3 N N 4 N N 4 N N 4 N N 4 N N A ILE 2 A ILE 2 HELX_P A CYS 7 A CYS 7 1 1 6 A SER 12 A SER 12 HELX_P A ASN 18 A ASN 18 1 2 7 B SER 9 B SER 9 HELX_P B CYS 19 B CYS 19 1 3 11 C ILE 2 C ILE 2 HELX_P C CYS 7 C CYS 7 1 4 6 C SER 12 C SER 12 HELX_P C ASN 18 C ASN 18 1 5 7 D SER 9 D SER 9 HELX_P D CYS 19 D CYS 19 1 6 11 disulf 2.049 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.091 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.016 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 disulf 2.081 C CYS 6 C SG CYS 6 1_555 C CYS 11 C SG CYS 11 1_555 disulf 2.060 C CYS 7 C SG CYS 7 1_555 D CYS 7 D SG CYS 7 1_555 disulf 2.017 C CYS 20 C SG CYS 20 1_555 D CYS 19 D SG CYS 19 1_555 covale 1.337 both B PHE 25 B C PHE 25 1_555 B MAA 26 B N MAA 26 1_555 covale 1.321 both B MAA 26 B C MAA 26 1_555 B THR 27 B N THR 27 1_555 covale 1.345 both D PHE 25 D C PHE 25 1_555 D MAA 26 D N MAA 26 1_555 covale 1.329 both D MAA 26 D C MAA 26 1_555 D THR 27 D N THR 27 1_555 metalc 3.144 A NA 2000 E NA NA 1_555 A HOH 2001 F O HOH 1_555 metalc 3.058 A NA 2000 E NA NA 1_555 B HOH 2019 G O HOH 1_555 metalc 2.620 A NA 2000 E NA NA 1_555 D HOH 2026 I O HOH 1_555 HORMONE CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, DIABETES MELLITUS B PHE 25 B PHE 25 1 B MAA 26 B MAA 26 4.55 D PHE 25 D PHE 25 1 D MAA 26 D MAA 26 12.89 INS_HUMAN UNP 1 P01308 INS_HUMAN UNP 2 P01308 90 110 2WRX 1 21 P01308 A 1 1 21 25 54 2WRX 1 30 P01308 B 2 1 30 90 110 2WRX 1 21 P01308 C 1 1 21 25 54 2WRX 1 30 P01308 D 2 1 30 2 TYR engineered mutation MAA 26 2WRX B P01308 UNP 50 26 4 TYR engineered mutation MAA 26 2WRX D P01308 UNP 50 26 BINDING SITE FOR RESIDUE NA A 2000 A NA 2000 Software 2 B HOH 2019 G HOH 2 1_555 D HOH 2026 I HOH 2 1_555 92 P 41 21 2